IL70034A0 - Heterocyclic amino compounds,their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclic amino compounds,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL70034A0
IL70034A0 IL70034A IL7003483A IL70034A0 IL 70034 A0 IL70034 A0 IL 70034A0 IL 70034 A IL70034 A IL 70034A IL 7003483 A IL7003483 A IL 7003483A IL 70034 A0 IL70034 A0 IL 70034A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
amino compounds
heterocyclic amino
Prior art date
Application number
IL70034A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL70034A0 publication Critical patent/IL70034A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IL70034A 1982-10-25 1983-10-24 Heterocyclic amino compounds,their preparation and pharmaceutical compositions containing them IL70034A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8230379 1982-10-25

Publications (1)

Publication Number Publication Date
IL70034A0 true IL70034A0 (en) 1984-01-31

Family

ID=10533819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70034A IL70034A0 (en) 1982-10-25 1983-10-24 Heterocyclic amino compounds,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4496579A (fr)
JP (1) JPS5998086A (fr)
KR (1) KR840006486A (fr)
AU (1) AU2055283A (fr)
BE (1) BE898072A (fr)
CH (1) CH661046A5 (fr)
DE (1) DE3338753A1 (fr)
ES (1) ES526738A0 (fr)
FI (1) FI833887A7 (fr)
FR (1) FR2534921B1 (fr)
GB (1) GB2129795B (fr)
GR (1) GR79405B (fr)
IL (1) IL70034A0 (fr)
IT (1) IT1212893B (fr)
LU (1) LU85059A1 (fr)
NL (1) NL8303673A (fr)
SE (1) SE8305866L (fr)
ZA (1) ZA837921B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds
DE3587511T2 (de) * 1984-04-24 1993-11-18 Glaxo Group Ltd Aromatische Diole.
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
GB8410459D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Chemical compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
DE10107243A1 (de) * 2001-02-16 2002-08-22 Bayer Ag Benzodioxinopyrrole, deren Herstellung und Verwendung
US8099200B2 (en) 2005-09-30 2012-01-17 Coombs Joshua D Vehicle interface based on the weight distribution of a user
US20070074922A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the torso of a user
US20070078569A1 (en) * 2005-09-30 2007-04-05 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US20070074921A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the appendages of a user
US20090076686A1 (en) * 2005-09-30 2009-03-19 Jeffrey Schox Vehicle interface to communicate a safety alert mode command

Also Published As

Publication number Publication date
BE898072A (fr) 1984-04-25
US4496579A (en) 1985-01-29
IT1212893B (it) 1989-11-30
IT8349214A0 (it) 1983-10-25
CH661046A5 (fr) 1987-06-30
SE8305866D0 (sv) 1983-10-25
SE8305866L (sv) 1984-04-26
FR2534921B1 (fr) 1987-01-16
FI833887A0 (fi) 1983-10-25
GB8328468D0 (en) 1983-11-23
FR2534921A1 (fr) 1984-04-27
GB2129795A (en) 1984-05-23
JPS5998086A (ja) 1984-06-06
ES8504200A1 (es) 1985-04-16
GB2129795B (en) 1986-02-12
AU2055283A (en) 1984-05-03
DE3338753A1 (de) 1984-04-26
ES526738A0 (es) 1985-04-16
LU85059A1 (fr) 1985-06-19
GR79405B (fr) 1984-10-22
NL8303673A (nl) 1984-05-16
FI833887A7 (fi) 1984-04-26
KR840006486A (ko) 1984-11-30
ZA837921B (en) 1985-04-24

Similar Documents

Publication Publication Date Title
IL68618A0 (en) Heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
IL69955A (en) 1-phenyl-2-piperidinoalkanol derivatives,their preparation and pharmaceutical compositions containing them
IL68913A (en) 3-aminoalkyl-1h-indole-5-alkan-sulphonamide derivatives,their preparation and pharmaceutical compositions containing them
IL69157A0 (en) Fluoromorphinan derivatives,their preparation and pharmaceutical compositions containing them
IL67826A0 (en) Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
DE3163938D1 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL65257A0 (en) Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them
IL68360A (en) Imidazopyrazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL68817A0 (en) Oxoazetidine derivatives,their preparation and pharmaceutical compositions containing them
IL68497A0 (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them
IL75794A0 (en) Aminophenol compounds,their preparation and pharmaceutical compositions containing them
IL87435A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL68586A0 (en) 4-aryl-4-piperidinecarbinols,their preparation and pharmaceutical compositions containing them
IL68699A0 (en) 3-phenoxy-1-azetidinecarboxamides,their preparation and pharmaceutical compositions containing them
IL68496A (en) 8-heteroarylalkyl-ergoline derivatives,their preparation and pharmaceutical compositions containing them
DE3380093D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL70508A (en) Pharmaceutical compositions containing aralkyltriazole derivatives,some such novel compounds and their preparation
IL70189A (en) 2-piperazinyl-quinazoline derivatives,their proeuction and pharmaceutical compositions containing them
DE3375391D1 (en) Indole compounds, their preparation and pharmaceutical compositions comprising them
IL70229A0 (en) 2-penem derivatives,their manufacture and pharmaceutical compositions containing them
IL72831A0 (en) 2-aminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
KE3749A (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL70401A0 (en) Ethenediamine and guanidine derivatives,their preparation and pharmaceutical compositions containing them
IL70273A (en) N-(substituted alkyl)acridanone-2-thiazole-2-yl-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
IL69010A (en) 15-alkoxyimino-14-oxoeburnamenines,their preparation and pharmaceutical compositions containing them